BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19781532)

  • 1. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
    Lapchak PA; Han MK
    Brain Res; 2009 Dec; 1303():144-50. PubMed ID: 19781532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence.
    Lapchak PA; Song D; Wei J; Zivin JA
    Exp Neurol; 2004 Aug; 188(2):286-91. PubMed ID: 15246828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits.
    Lapchak PA
    Brain Res; 2007 Sep; 1167():123-8. PubMed ID: 17673188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.
    Lapchak PA; Han MK
    Brain Res; 2010 Jul; 1344():217-25. PubMed ID: 20493175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury.
    Chen XR; Besson VC; Beziaud T; Plotkine M; Marchand-Leroux C
    J Pharmacol Exp Ther; 2008 Sep; 326(3):966-74. PubMed ID: 18562561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.